Becton, Dickinson and Company (BDX) Stock Analysis
A live, multi-source view of Becton, Dickinson and Company (BDX): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 72,000 employees · bd.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Becton, Dickinson and Company (BDX) had a market capitalization of $50.32B, a trailing P/E of 32.0 (forward 13.9), a dividend yield of 2.27% and a beta of 0.28; the shares traded in a 52-week range of $127.59 – $193.07 (24.6% over the year).
- Market cap
- $50.32B
- Enterprise value
- $66.42B
- Trailing P/E
- 32.0
- Forward P/E
- 13.9
- PEG ratio
- 1.11
- Price / book
- 2.06
- EPS (trailing)
- $5.78
- EPS (forward)
- $13.29
- Dividend yield
- 2.27%
- Payout ratio
- 72.5%
- Ex-dividend date
- 2026-09-09
- 52-week range
- $127.59 – $193.07
- 52-week change
- 24.6%
- Beta
- 0.28
- Average volume
- 2.1M
- Shares outstanding
- 272.4M
- Short % of float
- 3.92%
- Profit margin
- 4.2%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, Becton, Dickinson and Company (BDX) last closed at $184.74 (the last completed close before that scan).
Technicals at the scan: RSI 57 (neutral territory), price -0.8% versus its 20-day average, 20-day versus 50-day average spread +9.5%, MACD histogram -1.33.
Sentiment inputs: 71% of recent Finnhub-scored headlines read bullish; StockTwits 86% bullish; analyst consensus score 64/100.
Next scheduled company event: in 22 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 1 sell of BDX; corporate insiders filed 0 buys and 0 sells (2 distinct filers, latest disclosure 2026-07-21). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Alan Armstrong (1B/0S), Thomas H. Kean, Jr. (0B/1S). Who is trading what
RapidTradeView pick record
BDX has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Becton, Dickinson and Company (BDX) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell BDX.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.